SAN DIEGO, Nov. 7, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the chief in spine expertise innovation, centered on reworking spine surgical procedure with minimally disruptive, procedurally built-in options, introduced at present the industrial launch of the NuVasive Tube System (NTS) and Excavation Micro, a brand new minimally invasive surgical procedure (MIS) system that gives complete options for each TLIF and decompression. These additions increase the Firm’s entry and instrumentation expertise choices inside the NuVasive P360 portfolio.
“There’s a transparent alternative to remodel surgical procedure inside the $1.7 billion-dollar thoracolumbar posterior process phase and we’re seizing it with P360,” mentioned Ryan Donahoe, chief expertise officer at NuVasive. “Our P360 portfolio is now complemented by the launch of our NTS and Excavation Micro options which can be particularly designed to extend workflow pace whereas delivering improved security and reproducibility.”
Engineered to raise the surgical workflow by way of environment friendly, managed positioning, and optimized entry, NTS and Excavation Micro are made a whole procedural answer with Superior Supplies Science and expandable interbody implants, biologics, Reline fixation system, and enabling applied sciences inside the Pulse platform.
“The tube programs available on the market haven’t actually modified a lot up to now 20 years. Now with NTS, I’m in a position to sort out two procedures with the identical system by way of the unbelievable entry design—which additional extends NuVasive because the market chief in entry innovation,” mentioned Dr. David Yam, neurosurgeon in Portland, Oregon at Legacy Medical Group. “Even with extra advanced surgical procedures, I’m in a position full the case by way of a tube, moderately than reverting to an open process.”
NuVasive will characteristic its P360 portfolio on the upcoming NuVasive Innovation Occasion. On November 16, be a part of NuVasive nearly to listen to Firm management and surgeon companions focus on all complete procedural portfolios—P360, X360, C360, advanced, and the enabling applied sciences inside Pulse. Hear from surgeons on NTS, and their experiences with the great P360 portfolio addressing all the pieces from open TLIFs to MAS Midline procedures.
About NuVasive NuVasive, Inc. (NASDAQ: NUVA) is the chief in spine expertise innovation, with a mission to remodel surgical procedure, advance care, and alter lives. The Firm’s less-invasive, procedurally built-in surgical options are designed to ship reproducible and clinically confirmed outcomes. The Firm’s complete procedural portfolio contains surgical entry devices, spinal implants, fixation programs, biologics, software program for surgical planning, navigation and imaging options, magnetically adjustable implant programs for spine and orthopedics, and intraoperative neuromonitoring expertise and repair choices. With greater than $1 billion in web gross sales, NuVasive operates in additional than 50 international locations serving surgeons, hospitals, and sufferers. For extra data, please go to www.nuvasive.com.
Ahead-Trying Statements NuVasive cautions you that statements included on this information launch that aren’t an outline of historic info are forward-looking statements that contain dangers, uncertainties, assumptions and different elements which, if they don’t materialize or show appropriate, might trigger NuVasive’s outcomes to vary materially from historic outcomes or these expressed or implied by such forward-looking statements. The potential dangers and uncertainties which contribute to the unsure nature of those statements embody, amongst others, dangers related to acceptance of the Firm’s surgical merchandise and procedures by spine surgeons and hospitals, improvement and acceptance of latest merchandise or product enhancements, medical and statistical verification of the advantages achieved through the usage of NuVasive’s merchandise, the Firm’s potential to adequately handle stock because it continues to launch new merchandise, its potential to recruit and retain administration and key personnel, and the opposite dangers and uncertainties described in NuVasive’s information releases and periodic filings with the Securities and Trade Fee. NuVasive’s public filings with the Securities and Trade Fee can be found at www.sec.gov. NuVasive assumes no obligation to replace any forward-looking assertion to replicate occasions or circumstances arising after the date on which it was made.